A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms

NCT04755543 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Digestive System Neoplasms

Interventions

DRUG: LP002
DRUG: Cisplatin
DRUG: Fluorouracil
BIOLOGICAL: OH2 oncolytic virus

Sponsor

Taizhou HoudeAoke Biomedical Co., Ltd.